Wilmington, Delaware, Nov. 08, 2023 (GLOBE NEWSWIRE) --
Global Pediatric Clinical Trials Market value is estimated at US$ 14.6 billion in 2023 and is expected to grow at a significant CAGR of over 5% over the forecast period of 2023-2030, according to the latest market report by RationalStat
Market Definition, Market Scope, and Report Overview
The global pediatric clinical trials market is anticipated to grow at a moderate CAGR of around 5% during the forecast period of 2023-2030. The prevalence of chronic diseases such as cancer, diabetes, and obesity is increasing among children. This is driving the demand for pediatric clinical trials to develop new and improved treatments for these diseases. There is a growing awareness among parents and healthcare professionals of the importance of pediatric clinical trials. This is leading to more children participating in clinical trials.
Moreover, Governments across the globe are providing financial and other support for pediatric clinical trials. This is helping to accelerate the development of new and improved treatments for children. There have been significant advances in pediatric clinical trial design and methodology in recent years. This is making it easier and safer to conduct clinical trials with children.
- According to a deep-dive market assessment by RationalStat, the global pediatric clinical trials has been analyzed on the basis of market segments, including type, crop type, application and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global pediatric clinical trials covers market sizes on the basis of market value (US$/EUR Million) and volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global pediatric clinical trials. It also includes the industry's current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-pediatric-clinical-trials-market/#tab-ux_global_tab
Global Pediatric Clinical Trials Market: Segmental and Market Share Analysis
- On the basis of application, the Infectious Diseases segment dominates the global pediatric clinical trials market. This dominance is due to a number of factors such as the high prevalence of infectious diseases and lack of effective treatments for many infectious diseases.
Report Synopsis
Report Metrics | Details |
Base Year | 2023 |
Forecast Period | 2023-2030 |
Base Year Market Size | US$ 14.6 billion |
Market Size Forecast | US$ 20.6 billion |
Growth Rate | 5% |
Key Market Drivers |
|
Dominating Region |
|
Dominating Segment |
|
Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-pediatric-clinical-trials-market/#tab-ux_global_tab
Competition Analysis and Market Structure
These players adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers and acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global pediatric clinical trials include,
- In April 2023, Astellas Pharma Inc and Iveric bio, Inc. announced that the Companies have entered into a definitive agreement under which Astellas through Berry Merger Sub, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc., has agreed to acquire 100% of the outstanding shares of Iveric Bio.
Some of the prominent players and suppliers operating and contributing significantly to the global pediatric clinical trials growth include ICON plc, Syneos Health, Medpace, Inc., PPD, Inc., Premier Research, LabCorp Drug Development, QPS Holdings., Pfizer Inc., and The Emmes Company LLC, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-pediatric-clinical-trials-market/#tab-ux_global_tab
RationalStat has segmented the global pediatric clinical trials market based on phase, application, and region.
- Global Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- Global Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Application
- Infectious Diseases
- Oncology
- Autoimmune / inflammatory diseases
- Respiratory disorders
- Mental health disorders
- Others
- Global Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
- North America Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- US
- Canada
- Latin America Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Pediatric Clinical Trials Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Country
For more information about this report- https://store.rationalstat.com/store/global-pediatric-clinical-trials-market/
Key Questions Answered in the Pediatric Clinical Trials Report:
- What will be the market value of the global pediatric clinical trials by 2030?
- What is the market size of the global pediatric clinical trials?
- What are the market drivers of the global pediatric clinical trials?
- What are the key trends in the global pediatric clinical trials?
- Which is the leading region in the global pediatric clinical trials?
- What are the major companies operating in the global pediatric clinical trials?
- What are the market shares by key segments in the global pediatric clinical trials?
Running a year End discount of 20%-https://store.rationalstat.com/store/global-pediatric-clinical-trials-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Benign Prostatic Hyperpl Medication - Global Benign Prostatic Hyperpl Medication Market is expected to grow at a CAGR of 5.0% over the forecast period of 2022-2028.
- Global Red Light Therapy Device Market-Global Red Light Therapy Device Market is expected to grow at a significant CAGR of 4.2% over the forecast period of 2022-2028.
- US Pharmacy Market- US pharmacy market is anticipated to attain a value of US$ 706 million by 2030, growing at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
- Global Retinoblastoma Treatment Market- global retinoblastoma treatment market is anticipated to attain a value of US$ 3.0 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.
- Global Pet Relaxants Market- Global pet relaxants market is anticipated to attain a value of US$ 443 million by 2030, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
- Global Metastatic Colorectal Cancer Therapeutics Market- Global metastatic colorectal cancer therapeutics market is anticipated to attain a value of US$ 7.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.2% during the forecast period.
- Global Dermatology Lasers Market- Global Dermatology Lasers Market is expected to grow at a CAGR of 7.3% over the forecast period of 2022-2028
- Global Pharmaceutical Contract Manufacturing Market- Global pharmaceutical contract manufacturing market is anticipated to grow at a CAGR of 7.9%
- Global Biologics Contract Manufacturing Market- Global biologics contract manufacturing market is anticipated to grow at a CAGR of 9.5%
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data - Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest